Your browser doesn't support javascript.
loading
Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression.
Arakawa, Noriaki; Matsuyama, Shinichiro; Matsuoka, Masaru; Kitamura, Isao; Miyashita, Keiko; Kitagawa, Yutaro; Imai, Kazuo; Ogawa, Kumiko; Maeda, Takuya; Saito, Yoshiro; Hasegawa, Chihiro.
Affiliation
  • Arakawa N; Division of Medical Safety Science, National Institute of Health Sciences Kanagawa 210-9501, Japan.
  • Matsuyama S; Division of Medical Safety Science, National Institute of Health Sciences Kanagawa 210-9501, Japan.
  • Matsuoka M; Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan.
  • Kitamura I; Department of Clinical Laboratory, Nagoya City University East Medical Centre, Nagoya, Japan.
  • Miyashita K; Division of Medical Safety Science, National Institute of Health Sciences Kanagawa 210-9501, Japan.
  • Kitagawa Y; Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan.
  • Imai K; Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan; Department of Internal Medicine, Self-Defense Forces Central Hospital, Tokyo, Japan.
  • Ogawa K; Division of Pathology, National Institute of Health Sciences Kanagawa 210-9501, Japan.
  • Maeda T; Department of Clinical Laboratory, Saitama Medical University Hospital, Saitama, Japan.
  • Saito Y; Division of Medical Safety Science, National Institute of Health Sciences Kanagawa 210-9501, Japan. Electronic address: yoshiro@nihs.go.jp.
  • Hasegawa C; Department of Infectious Diseases, Nagoya City University East Medical Centre, Nagoya, Japan.
J Pharmacol Sci ; 150(1): 21-30, 2022 Sep.
Article in En | MEDLINE | ID: mdl-35926945
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lipopolysaccharide Receptors / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: J Pharmacol Sci Journal subject: FARMACOLOGIA Year: 2022 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lipopolysaccharide Receptors / COVID-19 Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: J Pharmacol Sci Journal subject: FARMACOLOGIA Year: 2022 Type: Article Affiliation country: Japan